SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-025660
Filing Date
2020-04-24
Accepted
2020-04-24 17:33:36
Documents
1
Period of Report
2020-03-25

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1509
  Complete submission text file 0001209191-20-025660.txt   3126
Mailing Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503
Business Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503 310-214-0065
Emmaus Life Sciences, Inc. (Issuer) CIK: 0000822370 (see all company filings)

IRS No.: 870419387 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 956 MAIN STREET DENNIS MA 02638
Business Address
Wood Jane Pine (Reporting) CIK: 0001810531 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35527 | Film No.: 20816301